Australia's most trusted
source of pharma news
Monday, 27 July 2026
Posted 27 July 2026 PM
Imugene announced to shareholders this morning that Leslie Chong will step down as CEO and Managing Director, effective immediately, for personal reasons, after nearly 11 years of service.
Chong joined the Sydney headquartered clinical-stage immune-oncology company in September 2015 as Chief Operating Officer before being promoted to CEO the following year. She was later appointed Managing Director.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.